Publications by authors named "F O Inofomoh"
Article Synopsis
- Dyslipidaemia is a major contributor to coronary artery disease (CAD) and cardiovascular issues globally, and understanding statin benefits is essential for its effective management.
- A web-based survey involving 313 physicians in Nigeria revealed that while most recognize elevated LDL-C as a key cause of CAD, many have concerns about statin side effects and their impact on patient adherence.
- The findings indicate significant knowledge and practice gaps in dyslipidaemia management among Nigerian physicians, suggesting a need for improvement initiatives to reduce cardiovascular risk.
Article Synopsis
- Nigeria has the highest global rate of peripartum cardiomyopathy, leading to a clinical trial that compared usual care with AI-guided screening for left ventricular systolic dysfunction (LVSD) in pregnant and postpartum women.
- The study involved 1,232 women, using digital stethoscopes and 12-lead electrocardiograms to identify LVSD, which was confirmed by echocardiography.
- Results showed that AI screening enhanced the detection rates of LVSD (4.1% vs. 2.0% for stethoscope AI; 3.4% vs. 2.0% for electrocardiogram AI), with no serious adverse events reported during the trial.
Background: COVID-19 cardiovascular research from Africa is limited. This study describes cardiovascular risk factors, manifestations, and outcomes of patients hospitalised with COVID-19 in the African region, with an overarching goal to investigate whether important differences exist between African and other populations, which may inform health policies.
Methods: A multinational prospective cohort study was conducted on adults hospitalised with confirmed COVID-19, consecutively admitted to 40 hospitals across 23 countries, 6 of which were African countries.
Background And Aims: Limited data exist on the cardiovascular manifestations and risk factors in people hospitalized with COVID-19 from low- and middle-income countries. This study aims to describe cardiovascular risk factors, clinical manifestations, and outcomes among patients hospitalized with COVID-19 in low, lower-middle, upper-middle- and high-income countries (LIC, LMIC, UMIC, HIC).
Methods: Through a prospective cohort study, data on demographics and pre-existing conditions at hospital admission, clinical outcomes at hospital discharge (death, major adverse cardiovascular events (MACE), renal failure, neurological events, and pulmonary outcomes), 30-day vital status, and re-hospitalization were collected.